A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis (clinicaltrials.gov) - Mar 6, 2026 - P1/2 | N=45 | Recruiting | Sponsor: Chiesi Farmaceutici S.p.A. | Trial completion date: Apr 2026 ➔ Aug 2026 | Trial primary completion date: Apr 2026 ➔ Aug 2026
Trial completion date • Trial primary completion date • Bronchiectasis • Pulmonary Disease • Respiratory Diseases
|